CanLiv Board of Directors:
Melanie B. Thomas, MD
President, CanLiv
Associate Director of Clinical Investigations,
Hollings Cancer Center
Grace E. DeWolff Chair of Medical Oncology
Associate Professor, Hollings Cancer Center, Medical University of South Carolina
Charleston, SC
Medical oncologist who specializes in treatment of and clinical research for patients with cancers of the bile ducts, gallbladder and liver.
Andrew X. Zhu, MD, PhD
Vice President, CanLiv
Director, Liver Cancer Research
Massachusettes General Hospital Cancer Center
Boston, MA
Medical oncologist who specializes in treatment of and clinical research for patients with cancers of the bile ducts, gallbladder and liver.
Melvyn H. Blum
Treasurer, CanLiv
New York City, NY
Family member of individual affected by hepatobiliary cancer
Matthew V. Byrne III, Esq
Secretary, CanLiv
Byrne, Costello, and Pickard, P.C.
Syracuse, NY
Attorney with extensive expertise in establishing philanthropic organizations
Alphonse E. Sirica, PhD
Board Member, CanLiv
Professor, Department of Pathology and Internal Medicine
Chair, Division of Cellular and Molecular Pathogenesis
Virginia Commonwealth University School of Medicine
Medical College of Virginia Campus
Richmond, VA
Scientist who focuses on basic and translational research in understanding the cancer mechanisms of bile duct cancers that can lead to new, effective treatments.
Peter Shamamian, MD
Board Member, CanLiv
Chief of Surgery, Department of Veteran Affairs
Professor, Department of Surgery, Medical University of South Carolina
Charleston, SC
Surgical oncologist who specializes in treatment of and research for patients with cancers of the bile ducts, liver and pancreas.
